# entry[].resource.text.div
The IHE FormatCode code set is defined to be the set of FormatCode(s) defined by IHE. This code set additionally includes format codes defined by the HL7 CDA. The set was listed in HITSP C80 Table 2-153 Format Code Value Set Definition. The use of the FormatCode specifies the technical format of the document. The FormatCode is a further specialization more detailed than the mime-type. The FormatCode provides sufficient information to allow any potential document consumer to know if it can process and/or display by identifying a document encoding, structure and template. The actual list of codes is intended to be extensible.

# entry[].resource.title
IHE Format Code set for use with Document Sharing

# entry[].resource.description
The IHE FormatCode code set is defined to be the set of FormatCode(s) defined by IHE http://wiki.ihe.net/index.php?title=IHE_Format_Codes. This code set additionally includes format codes defined by the HL7 CDA http://wiki.hl7.org/index.php?title=CDA_Format_Codes_for_IHE_XDS. The set was listed in HITSP C80 Table 2-153 Format Code Value Set Definition. The use of the FormatCode specifies the technical format of the document. The FormatCode is a further specialization more detailed than the mime-type. The FormatCode provides sufficient information to allow any potential document consumer to know if it can process and/or display by identifying a document encoding, structure and template. The actual list of codes is intended to be extensible.

# entry[].resource.concept[].display
Personal Health Records. Also known as HL7 CCD and HITSP C32

# entry[].resource.concept[].display
Emergency Department Encounter Summary (EDES)

# entry[].resource.concept[].display
Antepartum Record (APR) - History and Physical

# entry[].resource.concept[].display
Routine Interfacility Patient Transport (RIPT)

# entry[].resource.concept[].display
Basic Patient Privacy Consents with Scanned Document

# entry[].resource.concept[].definition
Code to be used when the mimeType is sufficient to understanding the technical format. May be used when no more specific FormatCode is available and the mimeType is sufficient to identify the technical format

# entry[].resource.concept[].display
Anatomic Pathology Structured Report All

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer All

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Breast

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Colon

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Prostate

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Thyroid

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Lung

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Skin

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Kidney

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Cervix

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Endometrium

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Ovary

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Esophagus

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Stomach

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Liver

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Pancreas

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Testis

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Urinary Bladder

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Lip Oral Cavity

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Pharynx

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Salivary Gland

# entry[].resource.concept[].display
Anatomic Pathology Structured Report Cancer Larynx

# entry[].resource.concept[].display
For documents following C-CDA 1.1 constraints using a structured body.

# entry[].resource.concept[].display
For documents following C-CDA 1.1 constraints using a non structured body.

# entry[].resource.concept[].display
For documents following C-CDA 2.1 constraints using a structured body.

# entry[].resource.concept[].display
For documents following C-CDA 2.1 constraints using a non structured body.

# entry[].resource.text.div
A supplement pack for http://hl7.org/fhir/CodeSystem/example that defines the administrative property 'legacy' for whether the test is currently performed

Code | Legacy
chol-mmol | false
chol-mass | true
chol | true

# entry[].resource.text.div
CodeSystem "ACME Codes for Cholesterol": This is an example code system that includes all the codes for serum cholesterol defined by ACME inc.

Developed by: FHIR project team (example)

Published for testing on 28-Jan 2016

This code system defines all the ACME codes for serum cholesterol:

Code | Display | Definition
chol-mmol | SChol (mmol/L) | Serum Cholesterol, in mmol/L
chol-mass | SChol (mg/L) | Serum Cholesterol, in mg/L
chol | SChol | Serum Cholesterol

# entry[].resource.title
ACME Codes for Cholesterol in Serum/Plasma

# entry[].resource.description
This is an example code system that includes all the ACME codes for serum/plasma cholesterol from v2.36.

# entry[].resource.filter[].description
An internal filter used to select codes that are only used with plasma

# entry[].resource.filter[].value
the value of this filter is either 'true' or 'false'

# entry[].resource.concept[].designation[].value
Obdurate Labs uses this with both kinds of units...

# entry[].resource.text.div
NHIN PurposeOfUse

This value set is suitable for use with the provenance resource. It is derived from, but not compatible with, the HL7 v3 Purpose of use Code system.

This code system http://healthit.gov/nhin/purposeofuse defines the following codes:

Code | Display | Definition
TREATMENT | Treatment | Treatment
PAYMENT | Payment | Payment
OPERATIONS | Operations | Healthcare Operations
SYSADMIN | Sysadmin | System Administration
FRAUD | Fraud | Fraud detection
PSYCHOTHERAPY | Psychotherapy | Use or disclosure of Psychotherapy Notes
TRAINING | Training | Use or disclosure by the covered entity for its own training programs
LEGAL | Legal | Use or disclosure by the covered entity to defend itself in a legal action
MARKETING | Marketing | Marketing
DIRECTORY | Directory | Use and disclosure for facility directories
FAMILY | Family | Disclose to a family member, other relative, or a close personal friend of the individual
PRESENT | Present | Uses and disclosures with the individual present.
EMERGENCY | Emergency | Permission cannot practicably be provided because of the individual's incapacity or an emergency.
DISASTER | Disaster | Use and disclosures for disaster relief purposes.
PUBLICHEALTH | Public Health | Uses and disclosures for public health activities.
ABUSE | Abuse | Disclosures about victims of abuse, neglect or domestic violence.
OVERSIGHT | Oversight | Uses and disclosures for health oversight activities.
JUDICIAL | Judicial | Disclosures for judicial and administrative proceedings.
LAW | Law Enforcement | Disclosures for law enforcement purposes.
DECEASED | Deceased | Uses and disclosures about decedents.
DONATION | Donation | Uses and disclosures for cadaveric organ, eye or tissue donation purposes
RESEARCH | Research | Uses and disclosures for research purposes.
THREAT | Threat | Uses and disclosures to avert a serious threat to health or safety.
GOVERNMENT | Government | Uses and disclosures for specialized government functions.
WORKERSCOMP | Worker's Comp | Disclosures for workers' compensation.
COVERAGE | Coverage | Disclosures for insurance or disability coverage determination
REQUEST | Request | Request of the Individual

# entry[].resource.publisher
Nationwide Health Information Network (NHIN)

# entry[].resource.description
This value set is suitable for use with the provenance resource. It is derived from, but not compatible with, the HL7 v3 Purpose of use Code system.

# entry[].resource.concept[].definition
Use or disclosure of Psychotherapy Notes

# entry[].resource.concept[].definition
Use or disclosure by the covered entity for its own training programs

# entry[].resource.concept[].definition
Use or disclosure by the covered entity to defend itself in a legal action

# entry[].resource.concept[].definition
Use and disclosure for facility directories

# entry[].resource.concept[].definition
Disclose to a family member, other relative, or a close personal friend of the individual

# entry[].resource.concept[].definition
Uses and disclosures with the individual present.

# entry[].resource.concept[].definition
Permission cannot practicably be provided because of the individual's incapacity or an emergency.

# entry[].resource.concept[].definition
Use and disclosures for disaster relief purposes.

# entry[].resource.concept[].definition
Uses and disclosures for public health activities.

# entry[].resource.concept[].definition
Disclosures about victims of abuse, neglect or domestic violence.

# entry[].resource.concept[].definition
Uses and disclosures for health oversight activities.

# entry[].resource.concept[].definition
Disclosures for judicial and administrative proceedings.

# entry[].resource.concept[].definition
Disclosures for law enforcement purposes.

# entry[].resource.concept[].definition
Uses and disclosures for cadaveric organ,  eye or tissue donation purposes

# entry[].resource.concept[].definition
Uses and disclosures for research purposes.

# entry[].resource.concept[].definition
Uses and disclosures to avert a serious threat to health or safety.

# entry[].resource.concept[].definition
Uses and disclosures for specialized government functions.

# entry[].resource.concept[].definition
Disclosures for insurance or disability coverage determination

# entry[].resource.text.div
SNOMED CT (all versions)

SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).

Copyright Statement: © 2002-2016 International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO http://www.ihtsdo.org/snomed-ct/get-snomed-ct

Properties

Code | URL | Description | Type
inactive | http://snomed.info/field/Concept.active | Whether the code is active or not (defaults to false). Not the same as deprecated | boolean
definitionStatusId | http://snomed.info/field/Concept.definitionStatusId | Either of the codes that are descendants of 900000000000444006 | code
Due to | http://snomed.info/id/42752001 | | code
Associated with | http://snomed.info/id/47429007 | | code
Associated morphology | http://snomed.info/id/116676008 | | code
Has specimen | http://snomed.info/id/116686009 | | code
Specimen source morphology | http://snomed.info/id/118168003 | | code
Specimen source topography | http://snomed.info/id/118169006 | | code
Specimen source identity | http://snomed.info/id/118170007 | | code
Specimen procedure | http://snomed.info/id/118171006 | | code
Part of | http://snomed.info/id/123005000 | | code
Has active ingredient | http://snomed.info/id/127489000 | | code
Subject of information | http://snomed.info/id/131195008 | | code
Causative agent | http://snomed.info/id/246075003 | | code
Associated finding | http://snomed.info/id/246090004 | | code
Component | http://snomed.info/id/246093002 | | code
Severity | http://snomed.info/id/246112005 | | code
Occurrence | http://snomed.info/id/246454002 | | code
Episodicity | http://snomed.info/id/246456000 | | code
Technique | http://snomed.info/id/246501002 | | code
Revision status | http://snomed.info/id/246513007 | | code
Units | http://snomed.info/id/246514001 | | code
After | http://snomed.info/id/255234002 | | code
Access | http://snomed.info/id/260507000 | | code
Method | http://snomed.info/id/260686004 | | code
Priority | http://snomed.info/id/260870009 | | code
Clinical course | http://snomed.info/id/263502005 | | code
Laterality | http://snomed.info/id/272741003 | | code
Associated procedure | http://snomed.info/id/363589002 | | code
Finding site | http://snomed.info/id/363698007 | | code
Laterality | http://snomed.info/id/363699004 | | code
Direct morphology | http://snomed.info/id/363700003 | | code
Direct substance | http://snomed.info/id/363701004 | | code
Has focus | http://snomed.info/id/363702006 | | code
Has intent | http://snomed.info/id/363703001 | | code
Procedure site | http://snomed.info/id/363704007 | | code
Has definitional manifestation | http://snomed.info/id/363705008 | | code
Indirect morphology | http://snomed.info/id/363709002 | | code
Indirect device | http://snomed.info/id/363710007 | | code
Has interpretation | http://snomed.info/id/363713009 | | code
Interprets | http://snomed.info/id/363714003 | | code
Measurement method | http://snomed.info/id/370129005 | | code
Property | http://snomed.info/id/370130000 | | code
Recipient category | http://snomed.info/id/370131001 | | code
Scale type | http://snomed.info/id/370132008 | | code
Specimen substance | http://snomed.info/id/370133003 | | code
Time aspect | http://snomed.info/id/370134009 | | code
Pathological process | http://snomed.info/id/370135005 | | code
Procedure site - Direct | http://snomed.info/id/405813007 | | code
Procedure site - Indirect | http://snomed.info/id/405814001 | | code
Procedure device | http://snomed.info/id/405815000 | | code
Procedure morphology | http://snomed.info/id/405816004 | | code
Finding context | http://snomed.info/id/408729009 | | code
Procedure context | http://snomed.info/id/408730004 | | code
Temporal context | http://snomed.info/id/408731000 | | code
Subject relationship context | http://snomed.info/id/408732007 | | code
Route of administration | http://snomed.info/id/410675002 | | code
Has dose form | http://snomed.info/id/411116001 | | code
Finding method | http://snomed.info/id/418775008 | | code
Finding informer | http://snomed.info/id/419066007 | | code
Using device | http://snomed.info/id/424226004 | | code
Using energy | http://snomed.info/id/424244007 | | code
Using substance | http://snomed.info/id/424361007 | | code
Surgical approach | http://snomed.info/id/424876005 | | code
Using access device | http://snomed.info/id/425391005 | | code
Role group | http://snomed.info/id/609096000 | | code
Property type | http://snomed.info/id/704318007 | | code
Inheres in | http://snomed.info/id/704319004 | | code
Towards | http://snomed.info/id/704320005 | | code
Characterizes | http://snomed.info/id/704321009 | | code
Process agent | http://snomed.info/id/704322002 | | code
Process duration | http://snomed.info/id/704323007 | | code
Process output | http://snomed.info/id/704324001 | | code
Relative to | http://snomed.info/id/704325000 | | code
Precondition | http://snomed.info/id/704326004 | | code
Direct site | http://snomed.info/id/704327008 | | code
Specified by | http://snomed.info/id/704346009 | | code
Observes | http://snomed.info/id/704347000 | | code
Is about | http://snomed.info/id/704647008 | | code

Filters

Code | Description | operator | Value
concept | Filter that includes concepts based on their logical definition. e.g. [concept] [is-a] [x] - include all concepts with an is-a relationship to concept x, or [concept] [in] [x]- include all concepts in the reference set identified by concept x | is-a in | A SNOMED CT code
expression | The result of the filter is the result of executing the given SNOMED CT Expression Constraint | = | A SNOMED CT ECL expression (see http://snomed.org/ecl)
expressions | Whether post-coordinated expressions are included in the value set | = | true or false

This code system http://snomed.info/sct defines many codes, but they are not represented here

# entry[].resource.description
SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).

# entry[].resource.copyright
© 2002-2016 International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO http://www.ihtsdo.org/snomed-ct/get-snomed-ct

# entry[].resource.filter[].description
Filter that includes concepts based on their logical definition. e.g. [concept] [is-a] [x] - include all concepts with an is-a relationship to concept x, or [concept] [in] [x]- include all concepts in the reference set identified by concept x

# entry[].resource.filter[].description
The result of the filter is the result of executing the given SNOMED CT Expression Constraint

# entry[].resource.filter[].value
A SNOMED CT ECL expression (see http://snomed.org/ecl)

# entry[].resource.filter[].description
Whether post-coordinated expressions are included in the value set

# entry[].resource.property[].description
Whether the code is active or not (defaults to false). Not the same as deprecated

# entry[].resource.property[].description
Either of the codes that are descendants of 900000000000444006

# entry[].resource.text.div
Code system summary example for ACME body sites

This is an example code system summary for the ACME codes for body site.

This code system http://hl7.org/fhir/CodeSystem/summary defines many codes, but they are not represented here

# entry[].resource.name
Code system summary example for ACME body sites

# entry[].resource.description
This is an example code system summary for the ACME codes for body site.

# entry[].resource.text.div
Condition Code

Code | Description | Comment | Version
... | No suggested values defined | | added v2.5.1
01 | Military service related | deprecated | added v2.3.1, removed after v2.4
02 | Condition is employment related | deprecated | added v2.3.1, removed after v2.4
03 | Patient covered by insurance not reflected here | deprecated | added v2.3.1, removed after v2.4
04 | HMO enrollee | deprecated | added v2.3.1, removed after v2.4
05 | Lien has been filed | deprecated | added v2.3.1, removed after v2.4
06 | ESRD patient in first 18 months of entitlement covered by employer group health insurance | deprecated | added v2.3.1, removed after v2.4
07 | Treatment of non-terminal condition for hospice patient | deprecated | added v2.3.1, removed after v2.4
08 | Beneficiary would not provide information concerning other insurance coverage | deprecated | added v2.3.1, removed after v2.4
09 | Neither patient nor spouse is employed | deprecated | added v2.3.1, removed after v2.4
10 | Patient and/or spouse is employed but no EGHP exists | deprecated | added v2.3.1, removed after v2.4
11 | Disabled beneficiary but no LGHP | deprecated | added v2.3.1, removed after v2.4
12 | Payer codes. | deprecated | added v2.3.1, removed after v2.4
12 ... 16 | Payer codes. | deprecated | added v2.3.1, removed after v2.4
13 | Payer codes. | deprecated | added v2.3.1, removed after v2.4
14 | Payer codes. | deprecated | added v2.3.1, removed after v2.4
15 | Payer codes. | deprecated | added v2.3.1, removed after v2.4
16 | Payer codes. | deprecated | added v2.3.1, removed after v2.4
18 | Maiden name retained | deprecated | added v2.3.1, removed after v2.4
19 | Child retains mother's name | deprecated | added v2.3.1, removed after v2.4
20 | Beneficiary requested billing | deprecated | added v2.3.1, removed after v2.4
21 | Billing for Denial Notice | deprecated | added v2.3.1, removed after v2.4
26 | VA eligible patient chooses to receive services in a Medicare certified facility | deprecated | added v2.3.1, removed after v2.4
27 | Patient referred to a sole community hospital for a diagnostic laboratory test | deprecated | added v2.3.1, removed after v2.4
28 | Patient and/or spouse's EGHP is secondary to Medicare | deprecated | added v2.3.1, removed after v2.4
29 | Disabled beneficiary and/or family member's LGHP is secondary to Medicare | deprecated | added v2.3.1, removed after v2.4
31 | Patient is student (full time-day) | deprecated | added v2.3.1, removed after v2.4
32 | Patient is student (cooperative/work study program) | deprecated | added v2.3.1, removed after v2.4
33 | Patient is student (full time-night) | deprecated | added v2.3.1, removed after v2.4
34 | Patient is student (Part time) | deprecated | added v2.3.1, removed after v2.4
36 | General care patient in a special unit | deprecated | added v2.3.1, removed after v2.4
37 | Ward accommodation as patient request | deprecated | added v2.3.1, removed after v2.4
38 | Semi-private room not available | deprecated | added v2.3.1, removed after v2.4
39 | Private room medically necessary | deprecated | added v2.3.1, removed after v2.4
40 | Same day transfer | deprecated | added v2.3.1, removed after v2.4
41 | Partial hospitalization | deprecated | added v2.3.1, removed after v2.4
46 | Non-availability statement on file | deprecated | added v2.3.1, removed after v2.4
48 | Psychiatric residential treatment centers for children and adolescents | deprecated | added v2.3.1, removed after v2.4
55 | SNF bed not available | deprecated | added v2.3.1, removed after v2.4
56 | Medical appropriateness | deprecated | added v2.3.1, removed after v2.4
57 | SNF readmission | deprecated | added v2.3.1, removed after v2.4
60 | Day outlier | deprecated | added v2.3.1, removed after v2.4
61 | Cost outlier | deprecated | added v2.3.1, removed after v2.4
62 | Payer code | deprecated | added v2.3.1, removed after v2.4
66 | Provider does not wish cost outlier payment | deprecated | added v2.3.1, removed after v2.4
67 | Beneficiary elects not to use life time reserve (LTR) days | deprecated | added v2.3.1, removed after v2.4
68 | Beneficiary elects to use life time reserve (LTR) days | deprecated | added v2.3.1, removed after v2.4
70 | Self-administered EPO | deprecated | added v2.3.1, removed after v2.4
71 | Full care in unit | deprecated | added v2.3.1, removed after v2.4
72 | Self-care in unit | deprecated | added v2.3.1, removed after v2.4
73 | Self-care training | deprecated | added v2.3.1, removed after v2.4
74 | Home | deprecated | added v2.3.1, removed after v2.4
75 | Home - 100% reimbursement | deprecated | added v2.3.1, removed after v2.4
76 | Back-up in facility dialysis | deprecated | added v2.3.1, removed after v2.4
77 | Provider accepts or is obligated/required due to a contractual arrangement or law to accept payment by a primary payer as payment in full | deprecated | added v2.3.1, removed after v2.4
78 | New coverage not implemented by HMO | deprecated | added v2.3.1, removed after v2.4
79 | Corf services provided off-site | deprecated | added v2.3.1, removed after v2.4
80 | Pregnant | deprecated | added v2.3.1, removed after v2.4

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0043 ( Condition code)

# entry[].resource.property[].description
A property that indicates the status of the concept. One of active, experimental, deprecated, retired

# entry[].resource.property[].description
The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged

# entry[].resource.concept[].display
Patient covered by insurance not reflected here

# entry[].resource.concept[].designation[].value
Patiënt verzekerd door verzekering niet zichtbaar hier

# entry[].resource.concept[].display
ESRD patient in first 18 months of entitlement covered by employer group health insurance

# entry[].resource.concept[].designation[].value
ESRD patiënt in eerste 18 maanden van toekenning gedekt door werkgever groepszorgpolis

# entry[].resource.concept[].display
Treatment of non-terminal condition for hospice patient

# entry[].resource.concept[].designation[].value
Behandeling van niet-terminale aandoening voor hospice patiënt

# entry[].resource.concept[].display
Beneficiary would not provide information concerning other insurance coverage

# entry[].resource.concept[].designation[].value
Begunstigde wilde geen informatie over andere verzekeringsdekking geven

# entry[].resource.concept[].display
Patient and/or spouse is employed but no EGHP exists

# entry[].resource.concept[].designation[].value
Patiënt en/of echtgenoot heeft werk maar er is geen EGHP

# entry[].resource.concept[].display
VA eligible patient chooses to receive services in a Medicare certified facility

# entry[].resource.concept[].designation[].value
VA-gerechtigde patiënt wil services in een Medicare gecertificeerde instelling

# entry[].resource.concept[].display
Patient referred to a sole community hospital for a diagnostic laboratory test

# entry[].resource.concept[].designation[].value
Patiënt verwezen naar één algemeen ziekenhuis voor diagnostische laboratoriumtest

# entry[].resource.concept[].display
Patient and/or spouse's EGHP is secondary to Medicare

# entry[].resource.concept[].designation[].value
Patiënt en/of echtgenoot EGHP is aanvullend op Medicare

# entry[].resource.concept[].display
Disabled beneficiary and/or family member's LGHP is secondary to Medicare

# entry[].resource.concept[].designation[].value
Gehandicapte begunstigde en/or familielid LGHP is aanvullend op Medicare

# entry[].resource.concept[].display
Patient is student (cooperative/work study program)

# entry[].resource.concept[].designation[].value
Patiënt is student (samenwerkend/werk studie programma)

# entry[].resource.concept[].designation[].value
Algemene zorg patiënt in speciale afdeling

# entry[].resource.concept[].display
Psychiatric residential treatment centers for children and adolescents

# entry[].resource.concept[].designation[].value
Psychiatrisch behandelcentra voor kinderen en adolescents

# entry[].resource.concept[].display
Provider does not wish cost outlier payment

# entry[].resource.concept[].designation[].value
Zorgaanbieder wil geen betaling van afwijkende kosten

# entry[].resource.concept[].display
Beneficiary elects not to use life time reserve (LTR) days

# entry[].resource.concept[].designation[].value
Begunstigde kiest ervoor niet de levenslange reserve dagen (LTR) te gebruiken

# entry[].resource.concept[].display
Beneficiary elects to use life time reserve (LTR) days

# entry[].resource.concept[].designation[].value
Begunstigde kiest ervoor  de levenslange reserve dagen (LTR) te gebruiken

# entry[].resource.concept[].display
Provider accepts or is obligated/required due to a contractual arrangement or law to accept payment by a primary payer as payment in full

# entry[].resource.concept[].designation[].value
Zorgaanbieder accepteert of is contractueel of juridisch verplicht om betaling te accepteren van een primaire betaler als volledige vertaling

# entry[].resource.concept[].designation[].value
Nieuwe dekking niet geïmplementeerd door HMO

# entry[].resource.text.div
Diagnosis Type

Code | Description | Comment | Version
A | Admitting | | added v2.3
F | Final | | added v2.3
W | Working | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0052 ( Diagnosis Type)

# entry[].resource.text.div
Referral Priority

Code | Description | Comment | Version
A | ASAP | | added v2.3
R | Routine | | added v2.3
S | STAT | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0280 ( Referral Priority)

# entry[].resource.text.div
Referral Type

Code | Description | Comment | Version
Hom | Home Care | | added v2.3
Lab | Laboratory | | added v2.3
Med | Medical | | added v2.3
Psy | Psychiatric | | added v2.3
Rad | Radiology | | added v2.3
Skn | Skilled Nursing | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0281 ( Referral Type)

# entry[].resource.text.div
Referral Disposition

Code | Description | Comment | Version
AM | Assume Management | | added v2.3
RP | Return Patient After Evaluation | | added v2.3
SO | Second Opinion | | added v2.3
WR | Send Written Report | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0282 ( Referral Disposition)

# entry[].resource.text.div
Referral Status

Code | Description | Comment | Version
A | Accepted | | added v2.3
E | Expired | | added v2.3
P | Pending | | added v2.3
R | Rejected | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0283 ( Referral Status)

# entry[].resource.text.div
Referral Category

Code | Description | Comment | Version
A | Ambulatory | | added v2.3
E | Emergency | | added v2.3
I | Inpatient | | added v2.3
O | Outpatient | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0284 ( Referral Category)

# entry[].resource.text.div
Provider Role

Code | Description | Comment | Version
CP | Consulting Provider | | added v2.3
PP | Primary Care Provider | | added v2.3
RP | Referring Provider | | added v2.3
RT | Referred to Provider | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0286 ( Provider Role)

# entry[].resource.text.div
MIME base64 encoding characters

Code | Description | Comment | Version
(pad) | = | deprecated | added v2.3, removed after v2.4
0 | A | deprecated | added v2.3, removed after v2.4
1 | B | deprecated | added v2.3, removed after v2.4
10 | K | deprecated | added v2.3, removed after v2.4
11 | L | deprecated | added v2.3, removed after v2.4
12 | M | deprecated | added v2.3, removed after v2.4
13 | N | deprecated | added v2.3, removed after v2.4
14 | O | deprecated | added v2.3, removed after v2.4
15 | P | deprecated | added v2.3, removed after v2.4
16 | Q | deprecated | added v2.3, removed after v2.4
17 | R | deprecated | added v2.3, removed after v2.4
18 | S | deprecated | added v2.3, removed after v2.4
19 | T | deprecated | added v2.3, removed after v2.4
2 | C | deprecated | added v2.3, removed after v2.4
20 | U | deprecated | added v2.3, removed after v2.4
21 | V | deprecated | added v2.3, removed after v2.4
22 | W | deprecated | added v2.3, removed after v2.4
23 | X | deprecated | added v2.3, removed after v2.4
24 | Y | deprecated | added v2.3, removed after v2.4
25 | Z | deprecated | added v2.3, removed after v2.4
26 | a | deprecated | added v2.3, removed after v2.4
27 | b | deprecated | added v2.3, removed after v2.4
28 | c | deprecated | added v2.3, removed after v2.4
29 | d | deprecated | added v2.3, removed after v2.4
3 | D | deprecated | added v2.3, removed after v2.4
30 | e | deprecated | added v2.3, removed after v2.4
31 | f | deprecated | added v2.3, removed after v2.4
32 | g | deprecated | added v2.3, removed after v2.4
33 | h | deprecated | added v2.3, removed after v2.4
34 | I | deprecated | added v2.3, removed after v2.4
35 | j | deprecated | added v2.3, removed after v2.4
36 | k | deprecated | added v2.3, removed after v2.4
37 | l | deprecated | added v2.3, removed after v2.4
38 | m | deprecated | added v2.3, removed after v2.4
39 | n | deprecated | added v2.3, removed after v2.4
4 | E | deprecated | added v2.3, removed after v2.4
40 | o | deprecated | added v2.3, removed after v2.4
41 | p | deprecated | added v2.3, removed after v2.4
42 | q | deprecated | added v2.3, removed after v2.4
43 | r | deprecated | added v2.3, removed after v2.4
44 | s | deprecated | added v2.3, removed after v2.4
45 | t | deprecated | added v2.3, removed after v2.4
46 | u | deprecated | added v2.3, removed after v2.4
47 | v | deprecated | added v2.3, removed after v2.4
48 | w | deprecated | added v2.3, removed after v2.4
49 | x | deprecated | added v2.3, removed after v2.4
5 | F | deprecated | added v2.3, removed after v2.4
50 | y | deprecated | added v2.3, removed after v2.4
51 | z | deprecated | added v2.3, removed after v2.4
52 | 0 | deprecated | added v2.3, removed after v2.4
53 | 1 | deprecated | added v2.3, removed after v2.4
54 | 2 | deprecated | added v2.3, removed after v2.4
55 | 3 | deprecated | added v2.3, removed after v2.4
56 | 4 | deprecated | added v2.3, removed after v2.4
57 | 5 | deprecated | added v2.3, removed after v2.4
58 | 6 | deprecated | added v2.3, removed after v2.4
59 | 7 | deprecated | added v2.3, removed after v2.4
6 | G | deprecated | added v2.3, removed after v2.4
60 | 8 | deprecated | added v2.3, removed after v2.4
61 | 9 | deprecated | added v2.3, removed after v2.4
62 | + | deprecated | added v2.3, removed after v2.4
63 | / | deprecated | added v2.3, removed after v2.4
7 | H | deprecated | added v2.3, removed after v2.4
8 | I | deprecated | added v2.3, removed after v2.4
9 | J | deprecated | added v2.3, removed after v2.4

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0290 ( MIME base64 encoding Characters)

# entry[].resource.property[].description
A property that indicates the status of the concept. One of active, experimental, deprecated, retired

# entry[].resource.property[].description
The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged

# entry[].resource.text.div
Subtype of Referenced Data

Code | Description | Comment | Version
... | Source RFC 2046 | deprecated | added v2.6, removed after v2.8.2
BASIC | ISDN PCM audio data | | added v2.3
DICOM | Digital Imaging and Communications in Medicine | | added v2.3
FAX | Facsimile data | | added v2.3
GIF | Graphics Interchange Format | | added v2.3
HTML | Hypertext Markup Language | | added v2.3
JOT | Electronic ink data (Jot 1.0 standard) | | added v2.3
JPEG | Joint Photographic Experts Group | | added v2.3
Octet-stream | Uninterpreted binary data | | added v2.3
PICT | PICT format image data | | added v2.3
PostScript | PostScript program | | added v2.3
RTF | Rich Text Format | | added v2.3
SGML | Standard Generalized Markup Language (HL7 V2.3.1 and later) | | added v2.3.1
TIFF | TIFF image data | | added v2.3
x-hl7-cda-level-one | HL7 Clinical Document Architecture Level One document | Retained for backwards compatibility only as of v2.6 and CDA R 2. Preferred value is text/xml. | added v2.4
XML | Extensible Markup Language (HL7 V2.3.1 and later) | | added v2.3.1
… | Source RFC 2046 | deprecated | added v2.7.1, removed after v2.7.1

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0291 ( Subtype of Referenced Data)

# entry[].resource.property[].description
A property that indicates the status of the concept. One of active, experimental, deprecated, retired

# entry[].resource.property[].description
The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged

# entry[].resource.concept[].display
Digital Imaging and Communications in Medicine

# entry[].resource.concept[].designation[].value
Digital Imaging and Communications in Medicine

# entry[].resource.concept[].designation[].value
Electronische Inktgegevens (Jot 1.0 standaard)

# entry[].resource.concept[].display
Standard Generalized Markup Language (HL7 V2.3.1 and later)

# entry[].resource.concept[].designation[].value
Standard Generalized Markup Language (vanaf HL7 v2.3.1)

# entry[].resource.concept[].extension[].valueString
Retained for backwards compatibility only as of v2.6 and CDA R 2. Preferred value is text/xml.

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Alleen voor backward compatibiliteit vanaf v2.6 en CDAr2. Voorkeurswaarde is text/xml.

# entry[].resource.concept[].display
HL7 Clinical Document Architecture Level One document

# entry[].resource.concept[].designation[].value
HL7 Clinical Document Architecture Level One document

# entry[].resource.concept[].display
Extensible Markup Language (HL7 V2.3.1 and later)

# entry[].resource.concept[].designation[].value
Extensible Markup Language (vanaf HL7 v2.3.1)

# entry[].resource.text.div
Vaccines Administered

Code | Description | Comment | Version
01 | DTP | diphtheria, tetanus toxoids and pertussis vaccine | added v2.3, removed after v2.8.2
02 | OPV | poliovirus vaccine, live, oral | added v2.3, removed after v2.8.2
03 | MMR | measles, mumps and rubella virus vaccine | added v2.3, removed after v2.8.2
04 | M/R | measles and rubella virus vaccine | added v2.3, removed after v2.8.2
05 | measles | measles virus vaccine | added v2.3, removed after v2.8.2
06 | rubella | rubella virus vaccine | added v2.3, removed after v2.8.2
07 | mumps | mumps virus vaccine | added v2.3, removed after v2.8.2
08 | Hep B, adolescent or pediatric | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | added v2.3, removed after v2.8.2
09 | Td (adult) | tetanus and diphtheria toxoids, adsorbed for adult use | added v2.3, removed after v2.8.2
10 | IPV | poliovirus vaccine, inactivated | added v2.3, removed after v2.8.2
100 | pneumococcal conjugate | pneumococcal conjugate vaccine, polyvalent | added v2.4, removed after v2.8.2
101 | typhoid, ViCPs | typhoid Vi capsular polysaccharide vaccine | added v2.4, removed after v2.8.2
102 | DTP-Hib-Hep B | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | added v2.5, removed after v2.8.2
103 | meningococcal C conjugate | meningococcal C conjugate vaccine | added v2.5, removed after v2.8.2
104 | Hep A-Hep B | hepatitis A and hepatitis B vaccine | added v2.5, removed after v2.8.2
105 | vaccinia (smallpox) diluted | vaccinia (smallpox) vaccine, diluted | added v2.5, removed after v2.8.2
106 | DTaP, 5 pertussis antigens6 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | added v2.5, removed after v2.8.2
107 | DTaP, NOS | diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS | added v2.5, removed after v2.8.2
108 | meningococcal, NOS | meningococcal vaccine, NOS | added v2.5, removed after v2.8.2
109 | pneumococcal, NOS | pneumococcal vaccine, NOS | added v2.5, removed after v2.8.2
11 | pertussis | pertussis vaccine | added v2.3, removed after v2.8.2
110 | DTaP-Hep B-IPV | DTaP-hepatitis B and poliovirus vaccine | added v2.6, removed after v2.8.2
111 | influenza, live, intranasal | influenza virus vaccine, live, attenuated, for intranasal use | added v2.6, removed after v2.8.2
112 | tetanus toxoid, NOS | tetanus toxoid, NOS | added v2.6, removed after v2.8.2
113 | Td (adult) | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use | added v2.6, removed after v2.8.2
114 | meningococcal A,C,Y,W-135 diphtheria conjugate | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4) | added v2.6, removed after v2.8.2
115 | Tdap | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed | added v2.6, removed after v2.8.2
116 | rotavirus, pentavalent | rotavirus, live, pentavalent vaccine | added v2.6, removed after v2.8.2
117 | VZIG (IND) | varicella zoster immune globulin (Investigational New Drug) | added v2.6, removed after v2.8.2
118 | HPV, bivalent | human papilloma virus vaccine, bivalent | added v2.6, removed after v2.8.2
119 | rotavirus, monovalent | rotavirus, live, monovalent vaccine | added v2.6, removed after v2.8.2
12 | diphtheria antitoxin | diphtheria antitoxin | added v2.3, removed after v2.8.2
120 | DTaP-Hib-IPV | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | added v2.6, removed after v2.8.2
121 | zoster | zoster vaccine, live | added v2.6, removed after v2.8.2
122 | rotavirus, NOS1 | rotavirus vaccine, NOS | added v2.6, removed after v2.8.2
13 | TIG | tetanus immune globulin | added v2.3, removed after v2.8.2
14 | IG, NOS | immune globulin, NOS | added v2.3, removed after v2.8.2
15 | influenza, split (incl. purified surface antigen) | influenza virus vaccine, split virus (incl. purified surface antigen) | added v2.3, removed after v2.8.2
16 | influenza, whole | influenza virus vaccine, whole virus | added v2.3, removed after v2.8.2
17 | Hib, NOS | Haemophilus influenzae type b vaccine, conjugate NOS | added v2.3, removed after v2.8.2
18 | rabies, intramuscular injection | rabies vaccine, for intramuscular injection | added v2.3, removed after v2.8.2
19 | BCG | Bacillus Calmette-Guerin vaccine | added v2.3, removed after v2.8.2
20 | DTaP | diphtheria, tetanus toxoids and acellular pertussis vaccine | added v2.3, removed after v2.8.2
21 | varicella | varicella virus vaccine | added v2.3, removed after v2.8.2
22 | DTP-Hib | DTP-Haemophilus influenzae type b conjugate vaccine | added v2.3, removed after v2.8.2
23 | plague | plague vaccine | added v2.3, removed after v2.8.2
24 | anthrax | anthrax vaccine | added v2.3, removed after v2.8.2
25 | typhoid, oral | typhoid vaccine, live, oral | added v2.3, removed after v2.8.2
26 | cholera | cholera vaccine | added v2.3, removed after v2.8.2
27 | botulinum antitoxin | botulinum antitoxin | added v2.3, removed after v2.8.2
28 | DT (pediatric) | diphtheria and tetanus toxoids, adsorbed for pediatric use | added v2.3, removed after v2.8.2
29 | CMVIG | cytomegalovirus immune globulin, intravenous | added v2.3, removed after v2.8.2
30 | HBIG | hepatitis B immune globulin | added v2.3, removed after v2.8.2
31 | Hep A, pediatric, NOS | hepatitis A vaccine, pediatric dosage, NOS | added v2.3, removed after v2.8.2
32 | meningococcal | meningococcal polysaccharide vaccine (MPSV4) | added v2.3, removed after v2.8.2
33 | pneumococcal | pneumococcal polysaccharide vaccine | added v2.3, removed after v2.8.2
34 | RIG | rabies immune globulin | added v2.3, removed after v2.8.2
35 | tetanus toxoid | tetanus toxoid, adsorbed | added v2.3, removed after v2.8.2
36 | VZIG | varicella zoster immune globulin | added v2.3, removed after v2.8.2
37 | yellow fever | yellow fever vaccine | added v2.3, removed after v2.8.2
38 | rubella/mumps | rubella and mumps virus vaccine | added v2.3, removed after v2.8.2
39 | Japanese encephalitis | Japanese encephalitis vaccine | added v2.3, removed after v2.8.2
40 | rabies, intradermal injection | rabies vaccine, for intradermal injection | added v2.3, removed after v2.8.2
41 | typhoid, parenteral | typhoid vaccine, parenteral, other than acetone-killed, dried | added v2.3, removed after v2.8.2
42 | Hep B, adolescent/high risk infant2 | hepatitis B vaccine, adolescent/high risk infant dosage | added v2.3, removed after v2.8.2
43 | Hep B, adult4 | hepatitis B vaccine, adult dosage | added v2.3, removed after v2.8.2
44 | Hep B, dialysis | hepatitis B vaccine, dialysis patient dosage | added v2.3, removed after v2.8.2
45 | Hep B, NOS | hepatitis B vaccine, NOS | added v2.3, removed after v2.8.2
46 | Hib (PRP-D) | Haemophilus influenzae type b vaccine, PRP-D conjugate | added v2.3, removed after v2.8.2
47 | Hib (HbOC) | Haemophilus influenzae type b vaccine, HbOC conjugate | added v2.3, removed after v2.8.2
48 | Hib (PRP-T) | Haemophilus influenzae type b vaccine, PRP-T conjugate | added v2.3, removed after v2.8.2
49 | Hib (PRP-OMP) | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | added v2.3, removed after v2.8.2
50 | DTaP-Hib | DTaP-Haemophilus influenzae type b conjugate vaccine | added v2.3, removed after v2.8.2
51 | Hib-Hep B | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | added v2.3, removed after v2.8.2
52 | Hep A, adult | hepatitis A vaccine, adult dosage | added v2.3, removed after v2.8.2
53 | typhoid, parenteral, AKD (U.S. military) | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | added v2.3.1, removed after v2.8.2
54 | adenovirus, type 4 | adenovirus vaccine, type 4, live, oral | added v2.3.1, removed after v2.8.2
55 | adenovirus, type 7 | adenovirus vaccine, type 7, live, oral | added v2.3.1, removed after v2.8.2
56 | dengue fever | dengue fever vaccine | added v2.3.1, removed after v2.8.2
57 | hantavirus | hantavirus vaccine | added v2.3.1, removed after v2.8.2
58 | Hep C | hepatitis C vaccine | added v2.3.1, removed after v2.8.2
59 | Hep E | hepatitis E vaccine | added v2.3.1, removed after v2.8.2
60 | herpes simplex 2 | herpes simplex virus, type 2 vaccine | added v2.3.1, removed after v2.8.2
61 | HIV | human immunodeficiency virus vaccine | added v2.3.1, removed after v2.8.2
62 | HPV, quadrivalent | human papilloma virus vaccine, quadrivalent | added v2.3.1, removed after v2.8.2
63 | Junin virus | Junin virus vaccine | added v2.3.1, removed after v2.8.2
64 | leishmaniasis | leishmaniasis vaccine | added v2.3.1, removed after v2.8.2
65 | leprosy | leprosy vaccine | added v2.3.1, removed after v2.8.2
66 | Lyme disease | Lyme disease vaccine | added v2.3.1, removed after v2.8.2
67 | malaria | malaria vaccine | added v2.3.1, removed after v2.8.2
68 | melanoma | melanoma vaccine | added v2.3.1, removed after v2.8.2
69 | parainfluenza-3 | parainfluenza-3 virus vaccine | added v2.3.1, removed after v2.8.2
70 | Q fever | Q fever vaccine | added v2.3.1, removed after v2.8.2
71 | RSV-IGIV | respiratory syncytial virus immune globulin, intravenous | added v2.3.1, removed after v2.8.2
72 | rheumatic fever | rheumatic fever vaccine | added v2.3.1, removed after v2.8.2
73 | Rift Valley fever | Rift Valley fever vaccine | added v2.3.1, removed after v2.8.2
74 | rotavirus, tetravalent | rotavirus, live, tetravalent vaccine | added v2.3.1, removed after v2.8.2
75 | vaccinia (smallpox) | vaccinia (smallpox) vaccine | added v2.3.1, removed after v2.8.2
76 | Staphylococcus bacterio lysate | Staphylococcus bacteriophage lysate | added v2.3.1, removed after v2.8.2
77 | tick-borne encephalitis | tick-borne encephalitis vaccine | added v2.3.1, removed after v2.8.2
78 | tularemia vaccine | tularemia vaccine | added v2.3.1, removed after v2.8.2
79 | vaccinia immune globulin | vaccinia immune globulin | added v2.3.1, removed after v2.8.2
80 | VEE, live | Venezuelan equine encephalitis, live, attenuated | added v2.3.1, removed after v2.8.2
81 | VEE, inactivated | Venezuelan equine encephalitis, inactivated | added v2.3.1, removed after v2.8.2
82 | adenovirus, NOS1 | adenovirus vaccine, NOS | added v2.3.1, removed after v2.8.2
83 | Hep A, ped/adol, 2 dose | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | added v2.3.1, removed after v2.8.2
84 | Hep A, ped/adol, 3 dose | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | added v2.3.1, removed after v2.8.2
85 | Hep A, NOS | hepatitis A vaccine, NOS | added v2.3.1, removed after v2.8.2
86 | IG | immune globulin, intramuscular | added v2.3.1, removed after v2.8.2
87 | IGIV | immune globulin, intravenous | added v2.3.1, removed after v2.8.2
88 | influenza, NOS | influenza virus vaccine, NOS | added v2.3.1, removed after v2.8.2
89 | polio, NOS | poliovirus vaccine, NOS | added v2.3.1, removed after v2.8.2
90 | rabies, NOS | rabies vaccine, NOS | added v2.3.1, removed after v2.8.2
91 | typhoid, NOS | typhoid vaccine, NOS | added v2.3.1, removed after v2.8.2
92 | VEE, NOS | Venezuelan equine encephalitis vaccine, NOS | added v2.3.1, removed after v2.8.2
93 | RSV-MAb | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | added v2.4, removed after v2.8.2
94 | MMRV | measles, mumps, rubella, and varicella virus vaccine | added v2.4, removed after v2.8.2
95 | TST-OT tine test | tuberculin skin test; old tuberculin, multipuncture device | added v2.4, removed after v2.8.2
96 | TST-PPD intradermal | tuberculin skin test; purified protein derivative solution, intradermal | added v2.4, removed after v2.8.2
97 | TST-PPD tine test | tuberculin skin test; purified protein derivative, multipuncture device | added v2.4, removed after v2.8.2
98 | TST, NOS | tuberculin skin test; NOS | added v2.4, removed after v2.8.2
99 | RESERVED - do not use3 | RESERVED - do not use | added v2.4, removed after v2.8.2
998 | no vaccine administered5 | no vaccine administered | added v2.5, removed after v2.8.2
999 | unknown | unknown vaccine or immune globulin | added v2.4, removed after v2.8.2

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered)

# entry[].resource.property[].description
A property that indicates the status of the concept. One of active, experimental, deprecated, retired

# entry[].resource.property[].description
The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged

# entry[].resource.concept[].extension[].valueString
diphtheria, tetanus toxoids and pertussis vaccine

# entry[].resource.concept[].extension[].valueString
measles, mumps and rubella virus vaccine

# entry[].resource.concept[].extension[].valueString
hepatitis B vaccine, pediatric or pediatric/adolescent dosage

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hepatitis B vaccin, pediatrie of pediatrie/adolescent dosering

# entry[].resource.concept[].extension[].valueString
tetanus and diphtheria toxoids, adsorbed for adult use

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tetanus en difterie toxoïde, geadsorbeerd, voor volwassen gebruik

# entry[].resource.concept[].extension[].valueString
typhoid Vi capsular polysaccharide vaccine

# entry[].resource.concept[].extension[].valueString
DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
DKT-Haemophilus influenzae type b conjugaat en hepatitis b vaccin

# entry[].resource.concept[].extension[].valueString
diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
difterie, tetanus toxoïdes en acellulair kinkhoest vaccin, 5 kinkhoest antigenen

# entry[].resource.concept[].extension[].valueString
diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
difterie, tetanus toxoïdes en acellulair kinkhoest vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
meningokokken vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
pneumokokken vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
influenza virus vaccine, live, attenuated, for intranasal use

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
influenza virus vaccin, live, verzwakt, for intranasaal gebruik

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tetanus toxoïde, niet anders gespecificeerd

# entry[].resource.concept[].designation[].value
tetanus toxoïde, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tetanus en difterie toxoïde, geadsorbeerd, zonder conserveringsmiddelen, voor volwassen gebruik

# entry[].resource.concept[].extension[].valueString
meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4)

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
meningokokken polysaccharide (groepen A, C, Y en W-135) difterie toxoïde conjugaat vaccin (MCV4)

# entry[].resource.concept[].extension[].valueString
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest vaccin, geadsorbeerd

# entry[].resource.concept[].designation[].value
tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest

# entry[].resource.concept[].extension[].valueString
varicella zoster immune globulin (Investigational New Drug)

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
varicella zoster immunoglobuline (Investigational New Drug)

# entry[].resource.concept[].extension[].valueString
diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
difterie, tetanus toxoïdes en acellulair kinkhoest vaccin, Haemophilus influenzae type b conjugaat, en poliovirus vaccin, inactief (DaKT-Hib-IPV)

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
rotavirus vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
influenza virus vaccine, split virus (incl. purified surface antigen)

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
influenza virus vaccin, gesplitst virus (incl. gezuiverd oppervlakte antigen)

# entry[].resource.concept[].display
influenza, split (incl. purified surface antigen)

# entry[].resource.concept[].designation[].value
influenza, gesplitst (incl. gezuiverd oppervlakte antigen)

# entry[].resource.concept[].extension[].valueString
Haemophilus influenzae type b vaccine, conjugate NOS

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Haemophilus influenzae type b vaccin, conjugaat niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
rabies vaccine, for intramuscular injection

# entry[].resource.concept[].extension[].valueString
diphtheria, tetanus toxoids and acellular pertussis vaccine

# entry[].resource.concept[].extension[].valueString
DTP-Haemophilus influenzae type b conjugate vaccine

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
DKT-Haemophilus influenzae type b conjugaat vaccin

# entry[].resource.concept[].extension[].valueString
diphtheria and tetanus toxoids, adsorbed for pediatric use

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
difterie en tetanus toxoïde, geadsorbeerd voor pediatrie gebruik

# entry[].resource.concept[].extension[].valueString
hepatitis A vaccine, pediatric dosage, NOS

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hepatitis A vaccin, pediatrie dosering, niet anders gespecificeerd

# entry[].resource.concept[].designation[].value
Hep A, pediatrie, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
rabies vaccine, for intradermal injection

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hondsdolheid vaccin, voor intradermale injectie

# entry[].resource.concept[].extension[].valueString
typhoid vaccine, parenteral, other than acetone-killed, dried

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tyfus vaccin, parenteraal, anders dan aceton-gedood, gedroogd

# entry[].resource.concept[].extension[].valueString
hepatitis B vaccine, adolescent/high risk infant dosage

# entry[].resource.concept[].extension[].valueString
hepatitis B vaccine, dialysis patient dosage

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hepatitis B vaccin, dialysepatiënt dosering

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hepatitis B vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
Haemophilus influenzae type b vaccine, PRP-D conjugate

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Haemophilus influenzae type b vaccin, PRP-D conjugaat

# entry[].resource.concept[].extension[].valueString
Haemophilus influenzae type b vaccine, HbOC conjugate

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Haemophilus influenzae type b vaccin, HbOC conjugaat

# entry[].resource.concept[].extension[].valueString
Haemophilus influenzae type b vaccine, PRP-T conjugate

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Haemophilus influenzae type b vaccin, PRP-T conjugaat

# entry[].resource.concept[].extension[].valueString
Haemophilus influenzae type b vaccine, PRP-OMP conjugate

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Haemophilus influenzae type b vaccin, PRP-OMP conjugaat

# entry[].resource.concept[].extension[].valueString
DTaP-Haemophilus influenzae type b conjugate vaccine

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
DaKT - Haemophilus influenzae type b conjugaat

# entry[].resource.concept[].extension[].valueString
Haemophilus influenzae type b conjugate and Hepatitis B vaccine

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Haemophilus influenzae type b conjugaat - Heb-B

# entry[].resource.concept[].extension[].valueString
typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tyfus vaccin, parenteraal, aceton-gedood, gedroogd (Amerikaanse leger)

# entry[].resource.concept[].display
typhoid, parenteral, AKD (U.S. military)

# entry[].resource.concept[].designation[].value
tyfus, parenteraal, AKD (Amerikaanse leger)

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
adenovirus vaccin, type 4, levend, oraal

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
adenovirus vaccin, type 7, levend, oraal

# entry[].resource.concept[].extension[].valueString
human papilloma virus vaccine, quadrivalent

# entry[].resource.concept[].extension[].valueString
respiratory syncytial virus immune globulin, intravenous

# entry[].resource.concept[].extension[].valueString
Venezuelan equine encephalitis, live, attenuated

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
adenovirus vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hepatitis A vaccin, pediatrie/adolescent dosering, 2 dosis schema

# entry[].resource.concept[].extension[].valueString
hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hepatitis A vaccin, pediatrie/adolescent dosering, 3 dosis schema

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hepatitis A vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
influenza virus vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
poliovirus vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
hondsdolheid vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tyfus vaccin, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
Venezuelan equine encephalitis vaccine, NOS

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Venezolaanse equïene encefalitis, niet anders gespecificeerd

# entry[].resource.concept[].extension[].valueString
measles, mumps, rubella, and varicella virus vaccine

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
bof, mazelen, rodehond en varicella virus vaccin

# entry[].resource.concept[].designation[].value
BMRV - bof, mazelen, rodehond en varicella

# entry[].resource.concept[].extension[].valueString
tuberculin skin test; old tuberculin, multipuncture device

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tuberculin skin test; old tuberculin, multipuncture device

# entry[].resource.concept[].extension[].valueString
tuberculin skin test; purified protein derivative solution, intradermal

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tuberculin skin test; purified protein derivative solution, intradermal

# entry[].resource.concept[].extension[].valueString
tuberculin skin test; purified protein derivative, multipuncture device

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tuberculin skin test; purified protein derivative, multipuncture device

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
tuberculin skin test; niet anders gespecificeerd

# entry[].resource.text.div
Time Selection Criteria Parameter Class Codes

Code | Description | Comment | Version
Fri | An indicator that Friday is or is not preferred for the day on which the appointment will occur. | In component 2, specify OK or NO. OK = Preferred appointment day NO = Day is not preferred | added v2.3
Mon | An indicator that Monday is or is not preferred for the day on which the appointment will occur. | In component 2, specify OK or NO. OK = Preferred appointment day NO = Day is not preferred | added v2.3
Prefend | An indicator that there is a preferred end time for the appointment request, service or resource. | In component 2, specify any valid time in the format HHMM, using 24-hour clock notation where HH = hour and MM = minutes | added v2.3
Prefstart | An indicator that there is a preferred start time for the appointment request, service or resource. | In component 2, specify any valid time in the format HHMM, using 24-hour clock notation where HH = hour and MM = minutes | added v2.3
Sat | An indicator that Saturday is or is not preferred for the day on which the appointment will occur. | In component 2, specify OK or NO. OK = Preferred appointment day NO = Day is not preferred | added v2.3
Sun | An indicator that Sunday is or is not preferred for the day on which the appointment will occur. | In component 2, specify OK or NO. OK = Preferred appointment day NO = Day is not preferred | added v2.3
Thu | An indicator that Thursday is or is not preferred for the day on which the appointment will occur. | In component 2, specify OK or NO. OK = Preferred appointment day NO = Day is not preferred | added v2.3
Tue | An indicator that Tuesday is or is not preferred for the day on which the appointment will occur. | In component 2, specify OK or NO. OK = Preferred appointment day NO = Day is not preferred | added v2.3
Wed | An indicator that Wednesday is or is not preferred for the day on which the appointment will occur. | In component 2, specify OK or NO. OK = Preferred appointment day NO = Day is not preferred | added v2.3

# entry[].resource.title
v2 Time Selection Criteria Parameter Class Codes

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0294 ( Time Selection Criteria Parameter Class Codes)

# entry[].resource.concept[].extension[].valueString
In component 2, specify OK or NO.
OK = Preferred appointment day NO = Day is not preferred

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
OK = Voorkeursdag. NO = Dag heeft niet de voorkeur

# entry[].resource.concept[].display
An indicator that Friday is or is not preferred for the day on which the appointment will occur.

# entry[].resource.concept[].designation[].value
Indicator dat vrijdag wel of niet de voorkeur heeft als de dag waarop de afspraak plaats zal vinden.

# entry[].resource.concept[].extension[].valueString
In component 2, specify OK or NO.
OK = Preferred appointment day NO = Day is not preferred

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
OK = Voorkeursdag. NO = Dag heeft niet de voorkeur

# entry[].resource.concept[].display
An indicator that Monday is or is not preferred for the day on which the appointment will occur.

# entry[].resource.concept[].designation[].value
Indicator dat maandag wel of niet de voorkeur heeft als de dag waarop de afspraak plaats zal vinden.

# entry[].resource.concept[].extension[].valueString
In component 2, specify any valid time in the format HHMM, using 24-hour clock notation where HH = hour and MM = minutes

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Geef in component 2 een tijd met formaat UUMM op basis van de 24-uurs kloknotatie, waarbij UU = uren en MM = minuten

# entry[].resource.concept[].display
An indicator that there is a preferred end time for the appointment request, service or resource.

# entry[].resource.concept[].designation[].value
De geprefereerde eindtijd voor de afspraakverzoek, service, of resource.

# entry[].resource.concept[].extension[].valueString
In component 2, specify any valid time in the format HHMM, using 24-hour clock notation where HH = hour and MM = minutes

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
Geef in component 2 een tijd met formaat UUMM op basis van de 24-uurs kloknotatie, waarbij UU = uren en MM = minuten

# entry[].resource.concept[].display
An indicator that there is a preferred start time for the appointment request, service or resource.

# entry[].resource.concept[].designation[].value
De geprefereerde starttijd voor de afspraakverzoek, service, of resource.

# entry[].resource.concept[].extension[].valueString
In component 2, specify OK or NO.
OK = Preferred appointment day NO = Day is not preferred

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
OK = Voorkeursdag. NO = Dag heeft niet de voorkeur

# entry[].resource.concept[].display
An indicator that Saturday is or is not preferred for the day on which the appointment will occur.

# entry[].resource.concept[].designation[].value
Indicator dat zaterdag wel of niet de voorkeur heeft als de dag waarop de afspraak plaats zal vinden.

# entry[].resource.concept[].extension[].valueString
In component 2, specify OK or NO.
OK = Preferred appointment day NO = Day is not preferred

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
OK = Voorkeursdag. NO = Dag heeft niet de voorkeur

# entry[].resource.concept[].display
An indicator that Sunday is or is not preferred for the day on which the appointment will occur.

# entry[].resource.concept[].designation[].value
Indicator dat zondag wel of niet de voorkeur heeft als de dag waarop de afspraak plaats zal vinden.

# entry[].resource.concept[].extension[].valueString
In component 2, specify OK or NO.
OK = Preferred appointment day NO = Day is not preferred

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
OK = Voorkeursdag. NO = Dag heeft niet de voorkeur

# entry[].resource.concept[].display
An indicator that Thursday is or is not preferred for the day on which the appointment will occur.

# entry[].resource.concept[].designation[].value
Indicator dat donderdag wel of niet de voorkeur heeft als de dag waarop de afspraak plaats zal vinden.

# entry[].resource.concept[].extension[].valueString
In component 2, specify OK or NO.
OK = Preferred appointment day NO = Day is not preferred

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
OK = Voorkeursdag. NO = Dag heeft niet de voorkeur

# entry[].resource.concept[].display
An indicator that Tuesday is or is not preferred for the day on which the appointment will occur.

# entry[].resource.concept[].designation[].value
Indicator dat dinsdag wel of niet de voorkeur heeft als de dag waarop de afspraak plaats zal vinden.

# entry[].resource.concept[].extension[].valueString
In component 2, specify OK or NO.
OK = Preferred appointment day NO = Day is not preferred

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
OK = Voorkeursdag. NO = Dag heeft niet de voorkeur

# entry[].resource.concept[].display
An indicator that Wednesday is or is not preferred for the day on which the appointment will occur.

# entry[].resource.concept[].designation[].value
Indicator dat woensdag wel of niet de voorkeur heeft als de dag waarop de afspraak plaats zal vinden.

# entry[].resource.text.div
CP Range Type

Code | Description | Comment | Version
F | Flat-rate. Apply the entire price to this interval, do not pro-rate the price if the full interval has not occurred/been consumed | | added v2.3
P | Pro-rate. Apply this price to this interval, pro-rated by whatever portion of the interval has occurred/been consumed | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0298 ( CP Range Type)

# entry[].resource.concept[].display
Flat-rate. Apply the entire price to this interval, do not pro-rate the price if the full interval has not occurred/been consumed

# entry[].resource.concept[].designation[].value
Vaste prijs. Pas de gehele prijs toe op dit interval, bereken niet naar rato in het geval dat niet het hele interval is opgetreden/is verbruikt

# entry[].resource.concept[].display
Pro-rate. Apply this price to this interval, pro-rated by whatever portion of the interval has occurred/been consumed

# entry[].resource.concept[].designation[].value
Pro rato. Pas deze prijs toe op dit interval, naar rato van het deel van het interval dat is opgetreden/is verbruikt

# entry[].resource.text.div
Encoding

Code | Description | Comment | Version
A | No encoding - data are displayable ASCII characters. | | added v2.3
Base64 | Encoding as defined by MIME (Multipurpose Internet Mail Extensions) standard RFC 1521. Four consecutive ASCII characters represent three consecutive octets of binary data. Base64 utilizes a 65-character subset of US-ASCII, consisting of both the upper and | The Request For Comment (RFC) 1521 standard is available at: http://www.ietf.org/rfc/rfc1521.txt | added v2.3
Hex | Hexadecimal encoding - consecutive pairs of hexadecimal digits represent consecutive single octets. | | added v2.3

# entry[].resource.description
FHIR Value set/code system definition for HL7 v2 table 0299 ( Encoding)

# entry[].resource.concept[].display
No encoding - data are displayable ASCII characters.

# entry[].resource.concept[].designation[].value
geen codering - gegevens zijn leesbare ASCII-tekens

# entry[].resource.concept[].extension[].valueString
The Request For Comment (RFC) 1521 standard is available at: http://www.ietf.org/rfc/rfc1521.txt

# entry[].resource.concept[].extension[]._valueString.extension[].extension[].valueString
De Request For Comment (RFC) 1521 standaard is vinden via: http://www.ietf.org/rfc/rfc1521.txt

# entry[].resource.concept[].display
Encoding as defined by MIME (Multipurpose Internet Mail Extensions) standard RFC 1521. Four consecutive ASCII characters represent three consecutive octets of binary data. Base64 utilizes a 65-character subset of US-ASCII, consisting of both the upper and

# entry[].resource.concept[].designation[].value
codering zoals gedefinieerd door MIME (Multipurpose Internet Mail Extensions) standaard RFC 1521. Vier opeenvolgende ASCII-tekens stellen drie, enkelvoudige octetten binaire gegevens voor. Base64 gebruikt een subset van 65-tekens uit US-ASCII, bestaande uit zowel de alfabetische hoofd- als de kleine letters, de cijfers "0" tot en met "9", "+", "/" en "=".

# entry[].resource.concept[].display
Hexadecimal encoding - consecutive pairs of hexadecimal digits represent consecutive single octets.

# entry[].resource.concept[].designation[].value
hexadecimale codering - paarsgewijze hexadecimale getallen stellen sequentiële, enkelvoudige octetten voor